TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|---|---|---|---|---|---|---|---|---|---|---|
| P | %ret | 1 | 1 | 1 | -1 | 11 | -5 | -38 | -51 | -74 | -26 |
| P | %wins | 0 | 100 | 0 | 0 | 0 | 0 | 17 |
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
12/27/07 16:30 | 12/24/07 | NGSX | Neurogesx Inc | CA | Health | Drug | Pharmaceutical Preparations | Arch Venture Partners V LP | IL | T | P.d | 2,362 | 6.18 | 0 | 382 | 19 | 2,444 | D | -30 | -28 | -14 | -1 | 3 | 0 | -1 | 11 | -5 | -38 | -51 | -74 | |||
3/22/04 21:28 | 3/19/04 | XCYT | Xcyte Therapies Inc | WA | Health | Drug | Pharmaceutical Preparations | Arch Venture Partners V LP | IL | T | P.d | 1,500 | 8.00 | 0 | 188 | 16 | 1,334 | I |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |